Company profile: Allivet
1.1 - Company Overview
Company description
- Provider of pet medications and supplements via a licensed pet pharmacy (tablets, chewables, suspensions), hard-to-find pet meds, veterinary supplies, and dog and cat care products, as well as farm and ranch tools. Offers an AutoShip subscription for regular deliveries with savings and free shipping on qualifying orders, serving domestic and international customers.
Products and services
- Pet Pharmacy: Licensed pet pharmacy orchestrates a streamlined ordering workflow and prescription verification to supply prescription medications and supplements for pets, ensuring accurate fulfillment and compliant handling
- Pet Medications: Prescription pet medications encompass tablets, chewables, and suspensions for various health conditions, enabling tailored dosing and administration formats for effective pet care
- AutoShip Service: Subscription-based service automatically delivers pet medications and supplements at regular intervals, offering savings and free shipping on qualifying orders
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Allivet
Bova
HQ: United Kingdom
Website
- Description: Provider of sterile and non-sterile products for the veterinary market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bova company profile →
Improve International
HQ: United Kingdom
Website
- Description: Provider of postgraduate training and CPD courses for veterinary practice staff across the UK, Republic of Ireland, Scandinavia and mainland Europe, offering postgraduate programs, certifications (ISVPS GPCert, PgC), Focus 20 short courses, the Academy Series, and online courses such as Canine and Feline Oncology with recorded lectures and webinars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Improve International company profile →
Vet Therapeutics
HQ: United States
Website
- Description: Provider of antibody-based therapies for pet cancer and chronic conditions, applying world-class science to bring human standard-of-care modalities to animal health and develop new products for companion animals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vet Therapeutics company profile →
Vetoquinol
HQ: France
Website
- Description: Provider of veterinary medicines and non-medicinal animal health products, developing, manufacturing and marketing solutions for livestock, poultry and companion animals, with a focus on innovation, proximity to customers, and the protection and welfare of animals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vetoquinol company profile →
VetMedux
HQ: United States
Website
- Description: Provider of a practice management system for veterinarians and digital resources, including Plumb's, a website and mobile app offering veterinary drug information and guidance for diagnosis and treatment, and Clinician's Brief, an educational resource delivering concise, practical information in digital and print formats.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VetMedux company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Allivet
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Allivet
2.2 - Growth funds investing in similar companies to Allivet
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Allivet
4.2 - Public trading comparable groups for Allivet
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →